Plant polyphenols as chemopreventive agents for lung cancer

International Journal of Molecular Sciences

Volumn 17, Issue 8, 2016, Pages

  Amararathna, Madumani ^a   Johnston, Michael R ^b   Vasantha Rupasinghe, H P ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Carcinogenesis; Chemoprevention; Diet; Fruits and vegetables; Lung cancer; Polyphenols

Indexed keywords

CARCINOGEN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; POLYPHENOL; ANTIOXIDANT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER RISK; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; GENOMIC INSTABILITY; HUMAN; LARGE CELL CARCINOMA; LIPID PEROXIDATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; ANIMAL; CHEMISTRY; FRUIT; LUNG NEOPLASMS; VEGETABLE;

ANIMALS; ANTIOXIDANTS; FRUIT; HUMANS; LUNG NEOPLASMS; POLYPHENOLS; VEGETABLES;

EID: 84983488997     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17081352     Document Type: Review

References (106)

1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359-E386. [CrossRef] [PubMed]
2. The American Cancer Society & LiveStrong. The Global Economic Cost of Cancer. Available online: http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf (accessed on 5 July 2016).
3. Morgan, E. Cancer Control: Knowledge into Action: WHO Guide for Effective Programmes; WHO: Geneva, Switzerland, 2007; Volume 2, pp. 1-49.
4. Anand, P.; Kunnumakara, A.B.; Sundaram, C.; Harikumar, K.B.; Tharakan, S.T.; Lai, O.S.; Sung, B.; Aggarwal, B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25, 2097-2116. [CrossRef] [PubMed]
5. Joint WHO; FAO Expert Consultation. Diet, Nutrition and the Prevention of chronic diseases. World Health Organ. Tech. Rep. Ser. 2003, 916, 1-8.
6. Buchner, F.L.; Bueno-de-Mesquita, H.B.; Linseisen, J.; Boshuizen, H.C.; Kiemeney, L.A.; Ros, M.M.; Overvad, K.; Hansen, L.; Tjonneland, A.; Raaschou-Nielsen, O., et al. Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European prospective investigation into cancer and nutrition (EPIC). Cancer Causes Control. 2010, 21, 357-371. [CrossRef] [PubMed]
7. Linseisen, J.; Rohrmann, S.; Miller, A.B.; Bueno-De-Mesquita, H.; Buchner, F.L.; Vineis, P.; Agudo, A.; Gram, I.T.; Janson, L.; Krogh, V., et al. Fruit and vegetable consumption and lung cancer risk: Updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 2007, 121, 1103-1114. [CrossRef] [PubMed]
8. Rupasinghe, H.P.V.; Nair, S.V.G.; Robinson, R.A. Chemopreventive properties of fruit phenolic compounds and their possible mode of actions. Stud. Nat. Prod. Chem. 2014, 42, 229-266.
9. Ferrazzano, G.F.; Amato, I.; Ingenito, A.; Zarrelli, A.; Pinto, G.; Pollio, A. Plant polyphenols and their anti-cariogenic properties: A review. Molecules 2011, 16, 1486-1507. [CrossRef] [PubMed]
10. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010, 2, 1231-1246. [CrossRef] [PubMed]
11. Adlercreutz, H.; Mazur, W. Phyto-oestrogens and Western diseases. Ann. Med. 1997, 29, 95-120. [CrossRef] [PubMed]
12. Bhagwat, S.; Haytowitz, D.B.; Holden, J.M. USDA Database for the Isoflavone Content of Selected Foods. Available online: http://www.ars.usda.gov/News/docs.htm?docid=6382 (accessed on 5 July 2016).
13. Ferrazzano, G.F.; Amato, I.; Ingenito, A.; Zarrelli, A.; Pinto, G.; Pollio, A. Flavonoid Content of U.S. Fruits, Vegetables, and Nuts. J. Agric. Food Chem. 2006, 54, 9966-9977.
14. Mattila, P.; Hellström, J.; Törrönen, R. Phenolic acids in berries, fruits, and beverages. J. Agric. Food Chem. 2006, 54, 7193-7199. [CrossRef] [PubMed]
15. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2009, 2, 270-278. [CrossRef] [PubMed]
16. Shahidi, F.; Naczk, M. Phenolics in Food and Nutraceuticals; Taylor & Francis: Boca Raton, FL, USA, 2004.
17. Spencer, J.P.E.; Abd El Mohsen, M.M.; Minihane, A.M.; Mathers, J.C. Biomarkers of the intake of dietary polyphenols: Strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99, 12-22. [CrossRef] [PubMed]
18. Guo, Q.; Zhao, B.; Li, M.; Shen, S.; Xin, W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta-Lipids Lipid Metab. 1996, 1304, 210-222. [CrossRef]
19. Denison, M.S.; Pandini, A.; Nagy, S.R.; Baldwin, E.P.; Bonati, L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 2002, 141, 3-24. [CrossRef]
20. Denison, M.S.; Nagy, S.R. Activation of the arylhydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 309-334. [CrossRef] [PubMed]
21. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008, 269, 315-325. [CrossRef] [PubMed]
22. Valentão, P.; Fernandes, E.; Carvalho, F.; Andrade, P.B.; Seabra, R.M.; Bastos, M.L. Hydroxyl radical and hypochlorous acid scavenging activity of small centaury (Centaurium erythraea) infusion. A comparative study with green tea (Camellia sinensis). Phytomedicine 2003, 10, 517-522.
23. Cos, P.; Ying, L.; Calomme, M.; Hu, J.P.; Cimanga, K.; van Poel, B.; Pieters, L.; Vlietinck, A.J.; Vanden, B. Dirk Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Nat. Prod. 1998, 61, 71-76. [CrossRef] [PubMed]
24. Parr, A.J.; Bolwell, G.P. Phenols in the plant and in man. The potential for possible nutritional enhancement of the diet by modifying the phenols content or profile. J. Sci. Food Agric. 2000, 80, 985-1012. [CrossRef]
25. Jancova, P.; Anzenbacher, P.; Anzenbacherova, E. Phase II drug metabolizing enzymes. Biomed. Pap. 2010, 154, 103-116. [CrossRef]
26. Zhai, X.; Lin, M.; Zhang, F.; Hu, Y.; Xu, X.; Li, Y.; Liu, K.; Ma, X.; Tian, X.; Yao, J. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol. Nutr. Food Res. 2013, 57, 249-259. [CrossRef] [PubMed]
27. Xiao, H. Mechanisms underlying chemopreventive effects of flavonoids via multiple signaling nodes within Nrf2-ARE and AhR-XRE gene regulatory networks. Curr. Chem. Biol. 2013, 7, 151-176. [CrossRef]
28. Klaassen, C.D. Casarett and Doull’s Toxicology: The Basic Science of Poisons; McGraw-Hill Education: New York, NY, USA, 2001; pp. 15-1454.
29. Aoki, Y.; Sato, H.; Nishimura, N.; Takahashi, S.; Itoh, K.; Yamamoto, M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 2001, 173, 154-160. [CrossRef] [PubMed]
30. Aoki, Y.; Hashimoto, A.H.; Amanuma, K.; Matsumoto, M.; Hiyoshi, K.; Takano, H.; Masumura, K.I.; Itoh, K.; Nohmi, T.; Yamamoto, M. Enhanced spontaneous and benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice. Cancer Res. 2007, 67, 5643-5648. [CrossRef] [PubMed]
31. Knekt, P.; Jayvinen, R.; Seppsnen, R.; Helibvaara, M.; Teppo, L.; Pukkala, E. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 1997, 146, 223-230. [CrossRef] [PubMed]
32. Le Marchand, L.; Murphy, S.P.; Hankin, J.H.; Wilkens, L.R.; Kolonel, L.N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 2000, 92, 154-160. [CrossRef]
33. Russo, G.L. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 2007, 74, 533-544. [CrossRef] [PubMed]
34. Christensen, K.Y.; Naidu, A.; Parent, M.; Pintos, J.; Abrahamowicz, M.; Siemiatycki, J.; Koushik, A. The risk of lung cancer related to dietary intake of flavonoids. Nutr. Cancer 2012, 64, 964-974. [CrossRef] [PubMed]
35. Vaid, M.; Katiyar, S.K. Grape seed proanthocyanidins inhibit cigarette smoke condensate-induced lung cancer cell migration through inhibition of NADPH oxidase and reduction in the binding of p22phox and p47phox proteins. Mol. Carcinog. 2015, 54, E61-E71. [CrossRef] [PubMed]
36. Punathil, T.; Katiyar, S.K. Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2. Mol. Carcinog. 2009, 48, 232-242. [CrossRef] [PubMed]
37. Singh, T.; Sharma, S.D.; Katiyar, S.K. Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS ONE 2011, 6, e27444. [CrossRef] [PubMed]
38. Yang, J.; Hsia, T.; Kuo, H.; Chao, P.L.; Chou, C.; Wei, Y.; Chung, J. Inhibition of lung cancer cell growth by quercetin glucuronides via G 2/M arrest and induction of apoptosis. Drug Metab. Dispos. 2006, 34, 296-304. [CrossRef] [PubMed]
39. Li, Z.; Zhang, L.; Wang, H.; Ma, J.; Sun, J. Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1. Tumour Biol. 2014, 35, 111-116. [CrossRef] [PubMed]
40. Saha, A.; Kuzuhara, T.; Echigo, N.; Fujii, A.; Suganuma, M.; Fujiki, H. Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of “growth arrest and DNA damage inducible genes 45 and 153”. Biol. Pharm. Bull. 2010, 33, 1291-1299. [CrossRef] [PubMed]
41. Lee, H.; Kang, C.; Jung, E.S.; Kim, J.S.; Kim, E. Antimetastatic activity of polyphenol-rich extract of Ecklonia cava through the inhibition of the Akt pathway in A549 human lung cancer cells. Food Chem. 2011, 127, 1229-1236. [CrossRef] [PubMed]
42. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674. [CrossRef] [PubMed]
43. Herbst, R.S.; Heymach, J.V.; Lippman, S.M. Lung cancer. N. Engl. J. Med. 2008, 359, 1367-1380. [CrossRef] [PubMed]
44. Franklin, W.; Noguchi, M.; Gonzales, A. Molecular and cellular pathology of lung cancer. Princ. Pract. Lung Cancer 2010, 77, 287-324.
45. Hanahan, D.; Weinberg, R.A.; Francisco, S. The hallmarks of cancer review. University of California at San Francisco. Horm. Res. 2000, 100, 57-70.
46. Greenlee, R.T.; Murray, T.; Bolden, S.; Wingo, P.A. Cancer statistics, 2000. CA Cancer J. Clin. 2000, 50, 7-30. [CrossRef] [PubMed]
47. Travis, W.D.; Brambilla, E.; Müller-hermelink, H.K.; Harris, C.C. Pathology & genetics, tumours of the lung, pleura, thymus and heart. In World Health Organization Classification of Tumors 2004; IARC Press: Lyon, France, 2004; Volume 1, pp. 9-123.
48. Yakut, T.; Schulten, H.J.; Demir, A.; Frank, D.; Danner, B.; Egeli, Ü.; Gebitekin, C.; Kahler, E.; Gunawan, B.; Ürer, N., et al. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer 2006, 54, 293-301. [CrossRef] [PubMed]
49. Zimmermann, S.; Fontecedro, A.C.; Stahel, R.A.; Peters, S. Lung cancer. In Side Effects of Medical Cancer Therapy; Dicato, M.A., Ed.; Springer-Verlag: London, UK, 2013; pp. 119-138.
50. International Agency for Research on Cancer. Occupational exposures during Aluminium production. IARC Monogr. 2010, 2005, 215-224.
51. International Agency for Research on Cancer. Asenic and arcenic Compounds. IARC Monogr. 2004, 2002, 41-93.
52. Ding, X.; Boney-Montoya, J.; Owen, B.M.; Bookout, A.L.; Mangelsdorf, D.J.; Kliewer, S.A. Occupational and environmental causes of lung cancer. Clin. Chest Med. 2013, 16, 387-393.
53. International Agency for Research on Cancer. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). IARC Monogr. Eval. Carcinog. Risks Hum. 2011, 100C, 219-309.
54. IARCWorking Group on the Evaluation of Carcinogenic Risks to Humans. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr. Eval. Carcinog. Risks Hum. 2010, 92, 1-853.
55. International Agency for Research on Cancer. Beryllium and beryllium compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 2011, 100C, 95-120.
56. International Agency for Research on Cancer. Cadmium and cadmium compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 2011, 100C, 121-145.
57. International Agency for Research on Cancer. Bis (chloromethyl) ether and chloromethyl methyl ether. World Heal. Organ. 2009, 1987, 295-308.
58. International Agency for Research on Cancer. Chromium (VI) compounds. IARC Monogr. Arsen. Met. Fibres, Dusts Rev. Hum. Carcinog. 2012, 1989, 147-168.
59. International Agency for Research on Cancer. Silica dust, crystalline, in the form of quartz or cristobalite. IARC Monogr. Eval. Carcinog. Risks Hum. 2011, 100C, 355-405.
60. International Agency for Research on Cancer. Coal gasification. Iarc Monogr. Eval. Carcinog. Risks Hum. 2012, 100F, 145-152.
61. International Agency for Research on Cancer. Coke production. Ap 42 1995, 2005, 167-178.
62. International Agency for Research on Cancer. Summary of data reported and evaluation. World Heal. Organ. 2011, 105, 451-467.
63. International Agency for Research on Cancer. Indoor emissions from household combustion of coal. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 100E, 519-542.
64. International Agency for Research on Cancer. Occupational exposures during iron and steel founding. World Heal. Organ. 1987, 1987, 497-508.
65. International Agency for Research on Cancer. MOPP. World Heal. Organ. 2008, 1987, 63-92.
66. International Agency for Research on Cancer. Nickel and nickel compounds. IARC Monogr. Eval. Carcinog. Risks Hum. 2011, 100C, 169-218.
67. International Agency for Research on Cancer. N’-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 100E, 323-335.
68. International Agency for Research on Cancer. Occupational exposure as a painter. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 100F, 509-539.
69. International Agency for Research on Cancer. Internalized α-particle emitting. World Heal. Organ. 2001, 2000, 241-283.
70. International Agency for Research on Cancer. Occupational exposures in the rubber-manufacturing industry. World Heal. Organ. 1987, 100F, 541-562.
71. Öberg, M.; Woodward, A.; Jaakkola, M.S.; Peruga, A.; Prüss-Ustün, A. Global estimate of the burden of disease from second-hand smoke. World Heal. Organ. 2010, 1-81.
72. International Agency for Research on Cancer. Second-hand tobacco smoke. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 100E, 215-265.
73. International Agency for Research on Cancer. Soot, as found in occupational exposure of chimney sweeps. World Heal. Organ. 2010, 1987, 209-214.
74. International Agency for Research on Cancer. Sulfur mustard. World Heal. Organ. 2006, 1987, 437-450.
75. Cooper, D.N. The Molecular Genetics of Lung Cancer; Springer-Verlag: Berlin, Germany, 2005.
76. National Research Council. Health Effects of Exposure to Radon; National Academies Press: Washington, DC, USA, 1999.
77. Soria, J.; Kim, E.S.; Fayette, J.; Lantuejoul, S.; Deutsch, E.; Hong, W.K. Reviews chemoprevention of lung cancer. Lancet Oncol. 2003, 4, 659-669. [CrossRef]
78. Giudice, A.; Montella, M. Activation of the Nrf2-ARE signaling pathway: A promising strategy in cancer prevention. BioEssays 2006, 28, 169-181. [CrossRef] [PubMed]
79. Reuland, D.J.; Khademi, S.; Castle, C.J.; Irwin, D.C.; McCord, J.M.; Miller, B.F.; Hamilton, K.L. Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radic. Biol. Med. 2013, 56, 102-111. [CrossRef] [PubMed]
80. Tan, A.C.; Konczak, I.; Sze, D.M.Y.; Ramzan, I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutr. Cancer 2011, 63, 495-505. [CrossRef] [PubMed]
81. Wu, F.; Sun, H.; Kluz, T.; Clancy, H.A.; Kiok, K.; Costa, M. Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro. Toxicol. Appl. Pharmacol. 2012, 258, 166-175. [CrossRef] [PubMed]
82. Li, Y.B.; Zhong, Z.F.; Chen, M.W.; Bao, J.L.; Wu, G.S.; Zhang, Q.W.; Lee, S.M.Y.; Hoi, P.M.; Wang, Y.T. Bisdemethoxycurcumin increases Sirt1 to antagonize t-BHP-induced premature senescence in WI38 fibroblast cells. Evid.-Based Complement. Altern. Med. 2013, 2013, 851714. [CrossRef] [PubMed]
83. Kang, K.A.; Lee, K.H.; Zhang, R.; Piao, M.J.; Chae, S.; Kim, K.N.; Jeon, Y.J.; Park, D.B.; You, H.J.; Kim, J.S., et al. Caffeic acid protects hydrogen peroxide induced cell damage in WI-38 human lung fibroblast cells. Biol. Pharm. Bull. 2006, 29, 1820-1824. [CrossRef] [PubMed]
84. Tsuji, P.A.; Walle, T. Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 2006, 27, 1579-1585. [CrossRef] [PubMed]
85. Lee, Y.J.; Song, J.H.; Oh, M.H.; Lee, Y.J.; Kim, Y.B.; Im, J.H.; Lee, S.H. ERK1/2 activation in quercetin-treated BEAS-2B cell plays a role in Nrf2-driven HO-1 expression. Mol. Cell. Toxicol. 2011, 7, 347-355. [CrossRef]
86. Tan, X.; Jin, P.; Feng, L.; Song, J.; Sun, E.; Liu, W.; Shu, L.; Jia, X. Protective effect of luteolin on cigarette smoke extract-induced cellular toxicity and apoptosis in normal human bronchial epithelial cells via the Nrf2 pathway. Oncol. Rep. 2014, 31, 1855-1862. [PubMed]
87. Puppala, D.; Gairola, C.G.; Swanson, H.I. Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2007, 28, 639-647. [CrossRef] [PubMed]
88. Rajendran, P.; Ekambaram, G.; Sakthisekaran, D. Cytoprotective effect of mangiferin on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Basic Clin. Pharmacol. Toxicol. 2008, 103, 137-142. [CrossRef] [PubMed]
89. Balansky, R.; Ganchev, G.; Iltcheva, M.; Kratchanova, M.; Denev, P.; Kratchanov, C.; Polasa, K.; D’Agostini, F.; Steele, V.E.; de Flora, S. Inhibition of lung tumor development by berry extracts in mice exposed to cigarette smoke. Int. J. Cancer 2012, 131, 1991-1997. [CrossRef] [PubMed]
90. Kamaraj, S.; Anandakumar, P.; Jagan, S.; Ramakrishnan, G.; Devaki, T. Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. Eur. J. Pharmacol. 2010, 649, 320-327. [CrossRef] [PubMed]
91. Naveenkumar, C.; Raghunandhakumar, S.; Asokkumar, S.; Binuclara, J.; Devaki, T. Baicalein improves antioxidant status and membrane-bound enzymes during oxidative stress in benzo(a)pyrene-induced lung carcinogenesis in mice. Biomed. Prev. Nutr. 2012, 2, 138-144. [CrossRef]
92. Naveenkumar, C.; Raghunandakumar, S.; Asokkumar, S.; Binuclara, J.; Rajan, B.; Premkumar, T.; Devaki, T. Mitigating role of baicalein on lysosomal enzymes and xenobiotic metabolizing enzyme status during lung carcinogenesis of Swiss albino mice induced by benzo(a)pyrene. Fundam. Clin. Pharmacol. 2014, 28, 310-322. [CrossRef] [PubMed]
93. Bao, M.J.; Shen, J.; Jia, Y.L.; Li, F.F.; Ma, W.J.; Shen, H.J.; Shen, L.L.; Lin, X.X.; Zhang, L.H.; Dong, X.W., et al. Apple polyphenol protects against cigarette smoke-induced acute lung injury. Nutrition 2013, 29, 235-243. [CrossRef] [PubMed]
94. Bodduluru, L.N.; Kasala, E.R.; Madhana, R.M.; Barua, C.C.; Hussain, M.I.; Haloi, P.; Borah, P. Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int. Immunopharmacol. 2016, 30, 102-110. [CrossRef] [PubMed]
95. Ravichandran, N.; Suresh, G.; Ramesh, B.; Vijaiyan, S.G. Fisetin, a novel flavonol attenuates benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Food Chem. Toxicol. 2011, 49, 1141-1147. [CrossRef] [PubMed]
96. Jin, H.; Chen, J.X.; Wang, H.; Lu, G.; Liu, A.; Li, G.; Tu, S.; Lin, Y.; Yang, C.S. NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallate. Nutr. Cancer 2015, 67, 167-176. [CrossRef] [PubMed]
97. El-Kenawy, A.E.; Elshama, S.S.; Osman, H.H. Effects of Physalis peruviana L. on toxicity and lung cancer induction by nicotine derived nitrosamine ketone in rats. Asian Pac. J. Cancer Prev. 2015, 16, 5863-5868. [CrossRef]
98. Chan, S.T.; Chuang, C.H.; Yeh, C.L.; Liao, J.W.; Liu, K.L.; Tseng, M.J.; Yeh, S.L. Quercetin supplementation suppresses the secretion of pro-inflammatory cytokines in the lungs of Mongolian gerbils and in A549 cells exposed to benzo[a]pyrene alone or in combination with β-carotene: In vivo and ex vivo studies. J. Nutr. Biochem. 2012, 23, 179-185. [CrossRef] [PubMed]
99. Neuhouser, M.L.; Patterson, R.E.; Thornquist, M.D.; Caret, T.; Omenn, G.S.; King, I.B.; Goodman, G.E. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the β-carotene and retinol efficacy trial (CARET). Cancer Epidemiol. Biomark. Prev. 2003, 12, 350-358.
100. Zhong, L.; Goldberg, M.S.; Gao, Y.; Hanley, J.A.; Parent, M.; Jin, F. A Population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001, 12, 695-700. [CrossRef] [PubMed]
101. Feskanich, D.; Ziegler, R.G.; Michaud, D.S.; Giovannucci, E.L.; Speizer, F.E.; Willett, W.C.; Colditz, G. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J. Natl. Cancer Inst. 2000, 92, 1812-1823. [CrossRef] [PubMed]
102. Rachtan, J.; Sokolowski, A. Risk factors for lung cancer among women in Poland. Lung Cancer 1997, 18, 137-145. [CrossRef]
103. Yuan, J.; Stram, D.O.; Arakawa, K.; Lee, H.; Yu, M.C. Dietary cryptoxanthin and reduced risk of lung cancer: The Singapore Chinese Health Study. Cancer Epidemiol. Biomark. Prev. 2003, 12, 890-898.
104. Männistö, S.; Smith-Warner, S.A.; Spiegelman, D.; Albanes, D.; Anderson, K.; van Den Brandt, P.A.; Cerhan, J.R.; Colditz, G.; Feskanich, D.; Freudenheim, J.L., et al. Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol. Biomark. Prev. 2004, 13, 40-48. [CrossRef]
105. Büchner, F.L.; Bueno-de-Mesquita, H.B.; Ros, M.M.; Overvad, K.; Dahm, C.C.; Hansen, L.; Tjønneland, A.; Clavel-Chapelon, F.; Boutron-Ruault, M.C.; Touillaud, M., et al. Variety in fruit and vegetable consumption and the risk of lung cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomark. Prev. 2010, 19, 2278-2286. [CrossRef] [PubMed]
106. Holick, C.N.; Michaud, D.S.; Stolzenberg-Solomon, R.; Mayne, S.T.; Pietinen, P.; Taylor, P.R.; Virtamo, J.; Albanes, D. Dietary carotenoids, serum β-carotene, and retinol and risk of lung cancer in the α-tocopherol, β-carotene cohort study. Am. J. Epidemiol. 2002, 156, 536-547. [CrossRef] [PubMed]